A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
NCT01063998 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2013-11-08
Summary
The ultimate goal of this project is to develop a simple non-invasive method to screen patients for potential kidney tumors.
Conditions
Interventions
- OTHER
-
Urine Marker
Urinary KIM-1 measurements
Sponsors & Collaborators
-
William Beaumont Hospitals
collaborator OTHER -
Jason Hafron
lead OTHER
Principal Investigators
-
Jason Hafron, MD · Beaumont Hospitals
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Renal Cancer
NCT05785052 ·Status: RECRUITING
-
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
NCT00899860 ·Status: TERMINATED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
Novel Prognostic Markers in Renal Cancer
NCT01002937 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
NCT01004783 ·Status: COMPLETED
-
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067 ·Status: NOT_YET_RECRUITING
-
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
NCT03692533 ·Status: UNKNOWN ·Phase: NA
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
Procalcitonin as a Marker of Infection in Cancer Patients
NCT01227109 ·Status: UNKNOWN
-
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
NCT02499458 ·Status: COMPLETED
-
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
NCT06339138 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Optical Biopsy to Improve the Diagnosis of Kidney Cancer
NCT02073110 ·Status: UNKNOWN
-
Multi Institutional Study in Patient Presenting With Hematuria
NCT03122964 ·Status: UNKNOWN
-
Renal Cell Carcinoma Microenvironment Discovery Project
NCT04005183 ·Status: COMPLETED
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
NCT01514669 ·Status: ACTIVE_NOT_RECRUITING
-
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
NCT05223218 ·Status: UNKNOWN
-
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
NCT02664883 ·Status: ACTIVE_NOT_RECRUITING
-
Clearance of NNAL and Cotinine From Second-hand Smoke in Hair and Urine
NCT00863824 ·Status: WITHDRAWN
-
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
NCT01118078 ·Status: COMPLETED